Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for COPD patients
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Among patients treated with Symbicort Turbuhaler due to chronic obstructive pulmonary disease(COPD), those who received the drug for the first time.
Clareo Health | Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients
